John P Marinelli, Hans A Herberg, Lindsay S Moore, Kristen L Yancey, Emily Kay-Rivest, Garrett G Casale, Allison Durham, Karl R Khandalavala, Morten Lund-Johansen, Nikitha Kosaraju, Christine M Lohse, Neil S Patel, Richard K Gurgel, Seilesh C Babu, John G Golfinos, J Thomas Roland, Jacob B Hunter, J Walter Kutz, Peter L Santa Maria, Michael J Link, Øystein V Tveiten, Matthew L Carlson
{"title":"生长的前庭神经鞘瘤初级放射外科治疗的最佳时机:从抢救显微手术结果的见解。","authors":"John P Marinelli, Hans A Herberg, Lindsay S Moore, Kristen L Yancey, Emily Kay-Rivest, Garrett G Casale, Allison Durham, Karl R Khandalavala, Morten Lund-Johansen, Nikitha Kosaraju, Christine M Lohse, Neil S Patel, Richard K Gurgel, Seilesh C Babu, John G Golfinos, J Thomas Roland, Jacob B Hunter, J Walter Kutz, Peter L Santa Maria, Michael J Link, Øystein V Tveiten, Matthew L Carlson","doi":"10.1002/ohn.1161","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Limited evidence guides the optimal timing of treatment after the detection of tumor growth during the observation of sporadic vestibular schwannoma (VS). The current work aimed to inform the timing of radiosurgical intervention based on an analysis of patient outcomes among those who ultimately failed stereotactic radiosurgery (SRS) and underwent salvage microsurgery.</p><p><strong>Study design: </strong>A historical cohort study.</p><p><strong>Setting: </strong>Seven centers across the United States and Norway.</p><p><strong>Methods: </strong>Adults with sporadic VS who underwent salvage microsurgery following failed primary SRS were included. The primary outcome of interest was the association between tumor size at the time of primary SRS and the ability to achieve gross total resection (GTR) and maintain postoperative House-Brackmann (HB) facial nerve grade I at the last follow-up after salvage microsurgery.</p><p><strong>Results: </strong>Among 96 patients, the median (interquartile range [IQR]) cerebellopontine angle (CPA) tumor size at primary SRS was 14.5 mm (10.0-19.0). Each 1-mm increase in CPA tumor size at the time of primary SRS was associated with a 13% increased likelihood of near-total/subtotal resection or most recent postoperative HB grade >I (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.05-1.21, P = .001), with an optimal tumor size threshold to distinguish this outcome of 12 mm of CPA extension (c-index 0.73). Similarly, for each 1-mm increase in CPA tumor size at the time of primary SRS, a 9% increase in any postoperative complication with salvage microsurgery was observed (OR 1.09, 95% CI 1.02-1.15, P = .009).</p><p><strong>Conclusion: </strong>Corroborated by size threshold surveillance data informing the timing of primary microsurgical resection, the current study suggests that VS outcomes are optimized when primary radiosurgical intervention is undertaken on growing tumors when they harbor 10-15 mm of cerebellopontine angle extension or less.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":"1717-1724"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimal Timing of Primary Radiosurgical Treatment of Growing Vestibular Schwannoma: Insights From Salvage Microsurgery Outcomes.\",\"authors\":\"John P Marinelli, Hans A Herberg, Lindsay S Moore, Kristen L Yancey, Emily Kay-Rivest, Garrett G Casale, Allison Durham, Karl R Khandalavala, Morten Lund-Johansen, Nikitha Kosaraju, Christine M Lohse, Neil S Patel, Richard K Gurgel, Seilesh C Babu, John G Golfinos, J Thomas Roland, Jacob B Hunter, J Walter Kutz, Peter L Santa Maria, Michael J Link, Øystein V Tveiten, Matthew L Carlson\",\"doi\":\"10.1002/ohn.1161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Limited evidence guides the optimal timing of treatment after the detection of tumor growth during the observation of sporadic vestibular schwannoma (VS). The current work aimed to inform the timing of radiosurgical intervention based on an analysis of patient outcomes among those who ultimately failed stereotactic radiosurgery (SRS) and underwent salvage microsurgery.</p><p><strong>Study design: </strong>A historical cohort study.</p><p><strong>Setting: </strong>Seven centers across the United States and Norway.</p><p><strong>Methods: </strong>Adults with sporadic VS who underwent salvage microsurgery following failed primary SRS were included. The primary outcome of interest was the association between tumor size at the time of primary SRS and the ability to achieve gross total resection (GTR) and maintain postoperative House-Brackmann (HB) facial nerve grade I at the last follow-up after salvage microsurgery.</p><p><strong>Results: </strong>Among 96 patients, the median (interquartile range [IQR]) cerebellopontine angle (CPA) tumor size at primary SRS was 14.5 mm (10.0-19.0). Each 1-mm increase in CPA tumor size at the time of primary SRS was associated with a 13% increased likelihood of near-total/subtotal resection or most recent postoperative HB grade >I (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.05-1.21, P = .001), with an optimal tumor size threshold to distinguish this outcome of 12 mm of CPA extension (c-index 0.73). Similarly, for each 1-mm increase in CPA tumor size at the time of primary SRS, a 9% increase in any postoperative complication with salvage microsurgery was observed (OR 1.09, 95% CI 1.02-1.15, P = .009).</p><p><strong>Conclusion: </strong>Corroborated by size threshold surveillance data informing the timing of primary microsurgical resection, the current study suggests that VS outcomes are optimized when primary radiosurgical intervention is undertaken on growing tumors when they harbor 10-15 mm of cerebellopontine angle extension or less.</p>\",\"PeriodicalId\":19707,\"journal\":{\"name\":\"Otolaryngology- Head and Neck Surgery\",\"volume\":\" \",\"pages\":\"1717-1724\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Otolaryngology- Head and Neck Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ohn.1161\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otolaryngology- Head and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ohn.1161","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:在散发性前庭神经鞘瘤(VS)的观察中,有限的证据指导发现肿瘤生长后的最佳治疗时机。目前的工作旨在通过对最终立体定向放射手术(SRS)失败并接受补救性显微手术的患者结果的分析,为放射外科干预的时机提供信息。研究设计:历史队列研究。环境:分布在美国和挪威的七个中心。方法:包括原发性SRS失败后接受补救性显微手术的散发性VS成人。主要观察结果是原发性SRS时肿瘤大小与修复性显微手术后最后一次随访时实现总切除(GTR)和维持术后House-Brackmann (HB)面神经I级的能力之间的关系。结果:96例患者中,原发性SRS时小脑桥脑角(CPA)肿瘤大小中位数(四分位间距[IQR])为14.5 mm(10.0 ~ 19.0)。原发性SRS时,CPA肿瘤大小每增加1毫米,近全切除/次全切除或最近一次术后HB分级为>I的可能性增加13%(优势比[or] 1.13, 95%可信区间[CI] 1.05-1.21, P = .001),最佳肿瘤大小阈值区分CPA扩展12毫米的结果(c指数0.73)。同样,在原发性SRS时,CPA肿瘤大小每增加1 mm,观察到任何术后显微手术并发症增加9% (OR 1.09, 95% CI 1.02-1.15, P = 0.009)。结论:根据大小阈值监测数据提供的初级显微手术切除时机的证实,目前的研究表明,当生长肿瘤的脑桥小脑角延伸10- 15mm或更小时,进行初级放射手术干预,VS结果最佳。
Optimal Timing of Primary Radiosurgical Treatment of Growing Vestibular Schwannoma: Insights From Salvage Microsurgery Outcomes.
Objective: Limited evidence guides the optimal timing of treatment after the detection of tumor growth during the observation of sporadic vestibular schwannoma (VS). The current work aimed to inform the timing of radiosurgical intervention based on an analysis of patient outcomes among those who ultimately failed stereotactic radiosurgery (SRS) and underwent salvage microsurgery.
Study design: A historical cohort study.
Setting: Seven centers across the United States and Norway.
Methods: Adults with sporadic VS who underwent salvage microsurgery following failed primary SRS were included. The primary outcome of interest was the association between tumor size at the time of primary SRS and the ability to achieve gross total resection (GTR) and maintain postoperative House-Brackmann (HB) facial nerve grade I at the last follow-up after salvage microsurgery.
Results: Among 96 patients, the median (interquartile range [IQR]) cerebellopontine angle (CPA) tumor size at primary SRS was 14.5 mm (10.0-19.0). Each 1-mm increase in CPA tumor size at the time of primary SRS was associated with a 13% increased likelihood of near-total/subtotal resection or most recent postoperative HB grade >I (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.05-1.21, P = .001), with an optimal tumor size threshold to distinguish this outcome of 12 mm of CPA extension (c-index 0.73). Similarly, for each 1-mm increase in CPA tumor size at the time of primary SRS, a 9% increase in any postoperative complication with salvage microsurgery was observed (OR 1.09, 95% CI 1.02-1.15, P = .009).
Conclusion: Corroborated by size threshold surveillance data informing the timing of primary microsurgical resection, the current study suggests that VS outcomes are optimized when primary radiosurgical intervention is undertaken on growing tumors when they harbor 10-15 mm of cerebellopontine angle extension or less.
期刊介绍:
Otolaryngology–Head and Neck Surgery (OTO-HNS) is the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation. The mission of Otolaryngology–Head and Neck Surgery is to publish contemporary, ethical, clinically relevant information in otolaryngology, head and neck surgery (ear, nose, throat, head, and neck disorders) that can be used by otolaryngologists, clinicians, scientists, and specialists to improve patient care and public health.